Kelly Walton

424 total citations
14 papers, 238 citations indexed

About

Kelly Walton is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kelly Walton has authored 14 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Kelly Walton's work include Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers) and Pregnancy and preeclampsia studies (2 papers). Kelly Walton is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers) and Pregnancy and preeclampsia studies (2 papers). Kelly Walton collaborates with scholars based in United States, Australia and United Kingdom. Kelly Walton's co-authors include Brian C. Betts, Claudio Anasetti, Joseph Pidala, David Woods, Jeffrey S. Weber, Rupal Ramakrishnan, Anders Berglund, Andressa S. Laino, Elizabeth M. Sagatys and Pedro Horna and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Kelly Walton

13 papers receiving 233 citations

Peers

Countries citing papers authored by Kelly Walton

Since Specialization

Citations

This map shows the geographic impact of Kelly Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Walton more than expected).

Fields of papers citing papers by Kelly Walton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Walton. The network helps show where Kelly Walton may publish in the future.

Co-authorship network of co-authors of Kelly Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Walton. A scholar is included among the top collaborators of Kelly Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Walton. Kelly Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results 2023 ·Blood ·Joseph Pidala, Shernan G. Holtan, Kelly Walton, Jongphil Kim, Hany Elmariah, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Claudio Anasetti, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller, Veronika Bachanová, (unknown), Brian C. Betts	1
2	Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results 2021 ·Clinical Cancer Research ·Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Michael L. Nieder, Elizabeth M. Sagatys, Shernan G. Holtan, Nicholas J. Lawrence, Harshani R. Lawrence, Bruce R. Blazar, Claudio Anasetti, Saı̈d M. Sebti, Brian C. Betts	15
3	Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease 2020 ·Journal of Clinical Investigation ·Bishwas Shrestha, Kelly Walton, (unknown), Elizabeth M. Sagatys, Nhan Tu, Justin C. Boucher, Gongbo Li, (unknown), Martin Felices, Jeffrey S. Miller, Joseph Pidala, Bruce R. Blazar, Claudio Anasetti, Brian C. Betts, Marco L. Davila	37
4	Biological and Clinical Impact of JAK2/mTOR Blockade in Gvhd Prevention: Preclinical and Phase I Trial Results 2020 ·Blood ·Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Michael L. Nieder, Nicholas J. Lawrence, Harshani R. Lawrence, Claudio Anasetti, Saı̈d M. Sebti, Brian C. Betts	0
5	Human CD83 Targeted Chimeric Antigen Receptor T Cell for the Prevention of Graft Versus Host Disease and Treatment of Myeloid Leukemia 2019 ·Blood ·Bishwas Shrestha, Kelly Walton, (unknown), Elizabeth M. Sagatys, Nhan Tu, Justin C. Boucher, (unknown), Joseph Pidala, Bruce R. Blazar, Claudio Anasetti, Brian C. Betts, Marco L. Davila	1
6	Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma 2018 ·Clinical Cancer Research ·David Woods, Rupal Ramakrishnan, Andressa S. Laino, Anders Berglund, Kelly Walton, Brian C. Betts, Jeffrey S. Weber	50
7	Imaging of acute abdominal pain in the third trimester of pregnancy 2018 ·BMJ ·Joshua Shur, Cecilia Bottomley, Kelly Walton, (unknown)	6
8	Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation 2018 ·Proceedings of the National Academy of Sciences ·Brian C. Betts, David Bastian, Supinya Iamsawat, Hung Nguyen, Jessica Heinrichs, Yongxia Wu, Anusara Daenthanasanmak, Anandharaman Veerapathran, Alison O’Mahony, Kelly Walton, (unknown), Pedro Horna, Elizabeth M. Sagatys, Marie Catherine Lee, Jack W. Singer, Ying‐Jun Chang, Chen Liu, Joseph Pidala, Claudio Anasetti, Xue‐Zhong Yu	53
9	Spontaneous Development of Cutaneous Squamous Cell Carcinoma in Mice with Cell-specific Deletion of Inhibitor of κB Kinase 2. 2017 ·PubMed ·Kelly S. Kirkley, Kelly Walton, Colleen Duncan, Ronald B. Tjalkens	5
10	Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T _reg and antitumor CTL function 2017 ·Science Translational Medicine ·Brian C. Betts, Anandharaman Veerapathran, Joseph Pidala, Hua Yang, Pedro Horna, Kelly Walton, Christopher Cubitt, Steven Gunawan, Harshani R. Lawrence, Nicholas J. Lawrence, Saı̈d M. Sebti, Claudio Anasetti	32
11	Transabdominal Ultrasound for Pregnancy Diagnosis in Reeves' Muntjac Deer 2014 ·Journal of Visualized Experiments ·Kelly Walton, Erin McNulty, Amy V. Nalls, Candace K. Mathiason	1
12	Comparison of 3 real-time, quantitative murine models of staphylococcal biofilm infection by using in vivo bioluminescent imaging. 2014 ·PubMed ·Kelly Walton, (unknown), Lon V. Kendall, Steven Dow	9
13	HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening 2012 ·PLoS ONE ·Kemperly Dynon, (unknown), Michelle Puryer, Ying Li, Kelly Walton, Yaeta Endo, Guiying Nie	27
14	Murine models of Staphylococcus aureus biofilm infections and therapeutic protein A vaccination 2007 ·Digital Collections of Colorado (Colorado State University) ·Kelly Walton, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact